Form 13-F position report

ETON PHARMACEUTICALS INC

Reported by EAM Investors LLC

ETON CUSIP 29772L108 Manager CIK 0001510989

Reported 139,210 shares, down 18,835 (11.9%) from the prior quarter.

Reported value 25.3%; share count -11.9% vs. the prior quarter.

Reduced
% of reported 13F value 0.74% This manager · Q3 2026
Shares 139,210 Quarter-end amount reported
Reported value $7,167,923 Fair value at quarter end
Consecutive quarters held 9 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-09-30 1070118
2023-12-31 0
2024-09-30 769656
2024-12-31 1265653
2025-03-31 1010272
2025-06-30 0
2025-09-30 1149452
2025-12-31 0
2026-03-31 1200016
2026-06-30 5721229
2026-09-30 7167923

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for ETON PHARMACEUTICALS INC held by EAM Investors LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 139,210 -18,835 (-11.9%) 0.74% $7,167,923 2026-11-16
Q2 2026 Added 158,045 +109,422 (225.0%) 0.51% $5,721,229 2026-08-13
Q1 2026 New 48,623 +48,623 (0.0%) 0.14% $1,200,016 2026-05-13
Q4 2025 Reduced 0 -52,897 (-100.0%) 0 $0 2026-02-12
Q3 2025 New 52,897 +52,897 (0.0%) 0.13% $1,149,452 2025-11-14
Q2 2025 Reduced 0 -77,833 (-100.0%) 0 $0 2025-08-12
Q1 2025 Reduced 77,833 -17,186 (-18.1%) 0.17% $1,010,272 2025-05-13
Q4 2024 Reduced 95,019 -33,257 (-25.9%) 0.18% $1,265,653 2025-02-13
Q3 2024 New 128,276 +128,276 (0.0%) 0.12% $769,656 2024-11-13
Q4 2023 Reduced 0 -256,623 (-100.0%) 0 $0 2024-02-14
Q3 2023 New 256,623 +256,623 (0.0%) 0.21% $1,070,118 2023-11-13

Who else reported the position

238 managers reported ETON PHARMACEUTICALS INC for Q3 2026.

Managers reporting ETON PHARMACEUTICALS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
EcoR1 Capital LLC Added 2,470,920 +298,982 5.65% $127,227,671 9 qtrs
Opaleye Management Inc Reduced 2,440,000 -420,000 14.15% $125,635,600 32 qtrs
BlackRock Inc Added 2,095,914 +200,081 < 0.01% $107,918,612 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 1,203,342 +226,772 < 0.01% $61,960,080 3 qtrs
Nantahala Capital Management LLC Reduced 875,507 -300,444 1.43% $45,079,855 10 qtrs
FMR LLC Added 823,587 +821,462 < 0.01% $42,406,452 7 qtrs
STATE STREET CORPORATION Added 775,543 +73,757 < 0.01% $39,932,709 26 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 764,398 +112,095 < 0.01% $39,368,003 26 qtrs
MORGAN STANLEY Reduced 513,174 -254,798 < 0.01% $26,423,338 32 qtrs
OBERWEIS ASSET MANAGEMENT INC Reduced 500,403 -1,197 0.58% $25,765,750 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
Common Stock

Voting authority reported

Sole
60,458
Shared
0
None
78,752

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.